Hemptown USA, a privately-owned grower of full-spectrum, feminized hemp using premium-seed genetics, recently lowered the price of its leading immunity-booster in response to the challenging times the world is facing, and the product rapidly sold out. Hemptown’s CBG IMMUNO CAPS are comprised of a proprietary blend of CBG (cannabigerol), CBD (cannabinoid), echinacea, elderberry, oregano and thyme. Now the company is offering Hemptown subscribers the opportunity to pre-order the product at the new price point of $59.99 before it becomes available to the general public. Products are anticipated to ship by Friday, April 10. Additionally, shoppers can boost their savings by bundling their purchase of IMMUNO CAPS with the company’s Harvest Blend CBD/CBG tincture for the low price of $99.99.
To pre-order Hemptown’s CBG IMMUNO CAPS, visit http://cnw.fm/5tY0b
About Hemptown USA
Hemptown USA is growing some of the finest cannabinoid-rich hemp plants in the world to meet the ever-increasing global demand for premium cannabinoid products. In total, the company cultivated more than 1,500 acres in three states – Oregon, Colorado and Kentucky. Expanded farmland spanning three states, together with extraction and processing capabilities, are the foundation for Hemptown USA’s vertically integrated model as the company pushes into the consumer packaged goods sectors with top-quality branded product lines. Due in large part to the recent acquisition of Kirkman Group, an FDA-licensed and cGMP (Current Good Manufacturing Practice) certified operating nutraceutical business based in Oregon, Hemptown USA is well-positioned to capitalize on a global market expected to exceed $22 billion by 2020. For more information, visit the company’s website at www.HemptownUSA.com.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.